COVID-19 precautions: Remote setup secure continued sample screening supporting cancer patients
2cureX has taken the necessary precautions in relation to the COVID-19 outbreak. These will not change the outlook for 2cureX’s coming market launch of IndiTreat.In accordance with the Danish government's recommendations, 2cureX has decided that those functions where it’s possible to work from home, will do so. Critical functions that support our laboratory activities will work in rotation in order to have uninterrupted delivery to our clinical and commercial partners. This exceptional situation is expected to be maintained until further guidance from the Danish Health ministry. Partners,